The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
ablynx | 1139 |
merck patent | 45 |
novartis | 30 |
wyeth | 27 |
boehringer ingelheim international | 26 |
vectura | 13 |
umc utrecht holding | 12 |
ablinks | 5 |
actogenix | 3 |
intrexon actobiotics | 3 |
ablynx | 172 |
merck patent | 16 |
umc utrecht holding | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
camelidae antibodies against immunoglobulin e and use thereof for the treatment of aller… 🛈 | 70 | 2002 |
serum albumin binding proteins | 69 | 2011 |
improved nanobodiestm against tumor necrosis factor-alpha | 56 | 2005 |
monovalent, bivalent and trivalent anti human respiratory syncytial virus (hrsv) nanobod… 🛈 | 39 | 2009 |
method for obtaining polypeptide constructs comprising two or more single domain antibod… 🛈 | 37 | 2007 |
amino acid sequences directed against il-17a, il-17f and/or il17-a/f and polypeptides co… 🛈 | 36 | 2011 |
formulations of single domain antigen binding molecules | 35 | 2008 |
improved amino acid sequences directed against il-6r and polypeptides comprising the sam… 🛈 | 33 | 2009 |
biparatopic abeta binding polypeptides | 32 | 2010 |
agonist dr5 binding polypeptides | 32 | 2010 |